Australia - English - Department of Health (Therapeutic Goods Administration)

bristol-myers squibb australia pty ltd - aztreonam, quantity: 1 g - injection, powder for - excipient ingredients: arginine - indications as at 23 may 1991: 1. azactam is indicated for use as a single agent in the treatment of infections known or strongly suspected to be due to susceptible gram negative aerobes, such as urinary tract infection, gonorrhoea, etc. 2. in combination with other suitable antibiotics to treat serious infections due to problem organisms known or likely to be susceptible to aztreonam. some patients with serious pseudomonas infections may benefit from concurrent use of azactam and an aminoglycoside because of synergistic action. however, this enhanced activity is not predictable. if such concurrent therapy is considered in patients with serious infections, susceptibility tests should be performed in vitro to determine the activity of the drugs in combination. because of the potential nephrotoxicity and ototoxicity of aminoglycoside antibiotics, renal function should be monitored according to the aminoglycoside manufacturer's prescribing information, especially if high dosages of the aminoglycoside are to be u

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

gilead sciences international ltd - aztreonam lysine - powder and solvent for nebuliser solution - 75mg

Singapore - English - HSA (Health Sciences Authority)

bristol-myers squibb (singapore) pte. ltd. - aztreonam - injection, powder, for solution - 1 g/vial - aztreonam 1 g/vial

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol-myers squibb pharmaceuticals ltd - aztreonam - powder for solution for injection - 1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol-myers squibb pharmaceuticals ltd - aztreonam - powder for solution for injection - 2gram

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bristol-myers squibb belgium sa-nv - aztreonam 1 g - powder for solution for injection - 1 g - aztreonam 1000 mg - aztreonam

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bristol-myers squibb belgium sa-nv - aztreonam 2 g - powder for solution for injection - 2 g - aztreonam 2000 mg - aztreonam

Australia - English - Department of Health (Therapeutic Goods Administration)

aztreonam -

Ireland - English - HPRA (Health Products Regulatory Authority)

bristol-myers squibb pharmaceuticals ltd - aztreonam - pdr for soln inj/inf - 500 milligram

Malta - English - Medicines Authority

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - aztreonam - powder for solution for infusion or injection - aztreonam 1 g - antibacterials for systemic use